FDA approves nasal spray for severe allergic reactions

A new device that uses a nasal spray instead of an injection to treat severe allergic reactions is headed to pharmacy shelves. According to the New York Times, the U.S. Food and Drug Administration (FDA) approved the device, called neffy, in August for emergency treatment of severe allergic reactions in adults and children who weigh more than 30 kilograms. Physicians say that neffy will make it easier to administer epinephrine to needle-averse patients and potentially stave off serious complications.